NCT07076121 · Interventional trial
A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
Overall registry status Active not recruiting
Phase 2 · Phase 3
Conditions Pancreatic Ductal Adenocarcinoma
Delaware Valley sites
- Thomas Jefferson University - Medical Oncology · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory